Biocept (BIOC) Stock Provides Another Opportunity To Buy

0

Biocept BIOC Stock NewsBiocept, Inc. (NASDAQ: BIOC)

Biocept is having an absolutely horrible day in the market today. Although, that may be concerning to some, to me, it’s a happy day. The stock is presenting yet another buying opportunity. Here’s why I say that…

Why Is BIOC Falling Today?

One big reason that I believe today’s declines are a perfect buying opportunity is the reason for the decline. If you try and find bad news about Biocept that pushed the stock down, it will prove to be a waste of time; that news simply doesn’t exist. What we’re seeing today is a sea of red in the market. Just look at your favorite stocks. No matter what sector they are in, I can just about guarantee that 4 out of every 5 are in the red. So, we’re not seeing asset specific declines today, we’re seeing market wide bloodshed; the type that’s not likely to last long.

Beyond Today’s Declines From Biocept

Subscribe to The Prudent Speculator
OK, if a market-wide correction draws the price of a horrible stock down, it doesn’t mean that the horrible stock is likely to see gains; I get that. However, BIOC isn’t a horrible stock. As a matter of fact, the company has done something absolutely amazing that is likely to change the way we diagnose cancer years from now. Biocept has successfully diagnosed breast cancer through the use of a simple blood sample in a study that compared the effectiveness of the company’s liquid biopsy technology to standard tissue biopsy technology used today. The results were a match! In the future, this could lead to early detection, higher survival rates, and for investors, a ton of profit!

What I Expect To See From Biocept Moving Forward

As you could imagine simply from the nature of this article, I’m expecting to see great things from BIOC in the future; both in the short-term and long-term view of things. Here’s why….

  • Short-Term – In the short term, we have to remember that price movements in the market are a series of overreactions. Today, we’re seeing a big one. So, it’s not unlikely that Biocept would pop back up by the end of the week to make up for today’s losses.
  • Long-Term – I talked about my long term outlook above. The bottom line is that BIOC is a great company that has made quite an advancement in the diagnostics industry; in the long run, this is highly likely to turn a profit.

What Do You Think?

Where do you think BIOC is headed and why? Let us know in the comments below!

LEAVE A REPLY

Please enter your comment!
Please enter your name here